[Remote] GRAIL Galleri Consultant (Carolinas) # 4403 at GRAIL

New Caledonia

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, BiotechnologyIndustries

Requirements

Reside within the Charlotte/Raleigh, NC territory and surrounding areas
Ability to spend the majority of time (>85%) making in-person visits to targeted physician practices, planning and supporting events, and executing company initiatives
Market builder mindset with urgency and passion to engage physicians and staff
Deep understanding of the Laboratory Developed Test (LDT) market, competitive landscape, and current cancer screening options

Responsibilities

Report directly to a GRAIL District Manager
Prospect and target primary care practices in the territory to generate interest in Galleri and identify/onboard early adopter customers
Represent a diverse team of professionals to enhance competitiveness and innovation
Collaborate with internal stakeholders, including executive sales leadership, marketing, customer service, billing, and other customer-facing functions, to provide on-the-ground feedback and shape strategies and execution plans
Develop and implement a business plan to support territory growth
Demonstrate and leverage understanding of the LDT market, competitive landscape, and cancer screening options in sales activities and growth execution
Meet or exceed sales goals by increasing breadth and depth of prescribing, maximizing promotional budgets, and executing the national sales strategy per GRAIL standards and management expectations
Identify marketplace opportunities, share best practices, and proactively communicate successful selling strategies to peers, management, cross-functional partners, and the Commercial Team
Manage implementation of all promotional activities to support sales and marketing strategies, in accordance with high industry standards and company policies
Collaborate with Medical Science Liaisons (MSLs) to educate providers

Skills

Sales

Physician Engagement

Healthcare Sales

Territory Management

MCED

Cancer Screening

Go-to-Market Strategy

GRAIL

Develops blood tests for early cancer detection

About GRAIL

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by its commitment to large-scale clinical studies that validate the effectiveness of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$1,765.5MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.

Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.

Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.

Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.

Risks

Potential overdiagnosis could impact the perceived value of GRAIL's tests.

Significant net losses may affect investor confidence and long-term sustainability.

High test costs may limit accessibility in markets with less healthcare funding.

Differentiation

GRAIL uses high-intensity sequencing for early cancer detection via blood tests.

The Galleri test screens for over 50 cancers with a single blood draw.

GRAIL's tests are supported by large-scale clinical studies ensuring reliability.

Upsides

Collaborations with platforms like Function Health expand Galleri test accessibility.

Revenue from Galleri grew 52% year-over-year, indicating strong market demand.

GRAIL's technology aligns with trends in personalized and preventative medicine.

Land your dream remote job 3x faster with AI

Try Jobo Free